UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-09 | 1.56 | 1.56 |
| Q1 2022 | 2022-05-09 | 4.04 | 4.04 |
| Q4 2021 | 2022-03-07 | 0.85 | 0.85 |
| Q3 2021 | 2021-11-09 | 0.56 | 0.56 |
| Q2 2021 | 2021-08-09 | 0.93 | 0.93 |
| Q1 2021 | 2021-05-10 | 0.24 | 0.24 |
| Q4 2020 | 2021-03-02 | 0.96 | 0.96 |
| Q3 2020 | 2020-11-02 | 1.17 | 0.51 |
| Q2 2020 | 2020-08-10 | 0.57 | -0.02 |
| 2016-06-20 | Downgrade | Mizuho | Buy to Neutral | $66.00 to $47.00 |
| 2016-06-13 | Reiterated Rating | RBC Capital | Buy | $78.00 |
| 2016-06-13 | Reiterated Rating | Royal Bank Of Canada | Buy | $78.00 |
| 2016-06-10 | Reiterated Rating | Mizuho | Buy | $66.00 |
| 2016-05-10 | Lower Price Target | RBC Capital | Outperform | $94.00 to $78.00 |
| 2016-05-06 | Reiterated Rating | Mizuho | Buy | $71.00 |
| 2016-04-07 | Reiterated Rating | Piper Jaffray | Overweight | $98.00 |
| 2016-04-07 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $98.00 |
| 2016-03-29 | Reiterated Rating | Mizuho | Buy | $71.00 |
| 2016-03-21 | Lower Price Target | RBC Capital | Outperform | $100.00 to $94.00 |
| 2016-03-18 | Lower Price Target | Piper Jaffray | Overweight | $121.00 to $98.00 |
| 2016-03-18 | Lower Price Target | Mizuho | Buy | $81.00 to $71.00 |
| 2016-02-26 | Reiterated Rating | Mizuho | Buy | $112.00 to $81.00 |
| 2016-02-14 | Reiterated Rating | Mizuho | Buy | $112.00 |
| 2016-01-31 | Reiterated Rating | William Blair | Outperform | $109.00 |
| 2016-01-31 | Reiterated Rating | Mizuho | Buy | $112.00 |
| 2016-01-11 | Reiterated Rating | Mizuho | Buy | $112.00 |
| 2016-01-06 | Reiterated Rating | RBC Capital | Outperform | $100.00 |
| 2015-12-17 | Reiterated Rating | Mizuho | Buy | $112.00 |
| 2015-12-09 | Reiterated Rating | William Blair | Buy | |
| 2015-12-08 | Initiated Coverage | Mizuho | Buy | $112.00 |
| 2015-11-12 | Reiterated Rating | Piper Jaffray | Buy | $120.00 to $97.00 |
| 2015-08-12 | Boost Price Target | Piper Jaffray | Overweight | $119.00 to $120.00 |
| 2015-07-29 | Boost Price Target | Piper Jaffray | Overweight | $94.00 to $119.00 |
| 2015-07-07 | Boost Price Target | William Blair | Outperform | $89.00 to $97.00 |
| 2015-07-06 | Boost Price Target | Piper Jaffray | Overweight | $75.00 to $94.00 |
| 2015-07-02 | Reiterated Rating | Cantor Fitzgerald | Buy | $95.00 to $92.00 |
| 2015-06-22 | Initiated Coverage | RBC Capital | Outperform | $97.00 |
| 2015-06-16 | Boost Price Target | Cantor Fitzgerald | Buy | $65.00 to $95.00 |
| 2015-05-14 | Reiterated Rating | Cantor Fitzgerald | Buy | $65.00 |
| 2015-04-20 | Boost Price Target | Piper Jaffray | Overweight | $55.00 to $75.00 |
| 2015-04-14 | Boost Price Target | Cantor Fitzgerald | Buy | $51.00 to $65.00 |
| 2015-04-06 | Set Price Target | Piper Jaffray | Buy | $55.00 |
| 2015-03-31 | Boost Price Target | Cantor Fitzgerald | Buy | $37.00 to $51.00 |
| 2015-02-18 | Boost Price Target | William Blair | Outperform | $25.00 to $43.00 |
| 2015-02-18 | Reiterated Rating | Cantor Fitzgerald | Buy | $30.00 to $37.00 |
| 2015-01-22 | Reiterated Rating | Cantor Fitzgerald | Buy | $30.00 |
| 2014-12-18 | Reiterated Rating | Cantor Fitzgerald | Buy | $30.00 |
| 2014-08-13 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 to $30.00 |
| 2014-03-10 | Initiated Coverage | William Blair | Outperform to Outperform | |
| 2014-03-10 | Initiated Coverage | Cantor Fitzgerald | Buy | $21.00 |
| 2014-03-10 | Initiated Coverage | Piper Jaffray | Overweight |
| 2016-06-20 | Downgrade | Mizuho | Buy to Neutral | $66.00 to $47.00 |
| 2016-06-13 | Reiterated Rating | RBC Capital | Buy | $78.00 |
| 2016-06-13 | Reiterated Rating | Royal Bank Of Canada | Buy | $78.00 |
| 2016-06-10 | Reiterated Rating | Mizuho | Buy | $66.00 |
| 2016-05-10 | Lower Price Target | RBC Capital | Outperform | $94.00 to $78.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In EGRX 140 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 1.86M |
| JANUS CAPITAL MANAGEMENT LLC | 1.45M |
| HENDERSON GROUP PLC | 1.24M |
| STATE STREET CORP | 1.01M |
| BlackRock Fund Advisors | 0.85M |
| Vanguard Group, Inc | 0.78M |
| BRANDES INVESTMENT PARTNERS, LP | 0.47M |
| DIMENSIONAL FUND ADVISORS LP | 0.36M |
| CITADEL ADVISORS LLC | 0.32M |
| ACADIAN ASSET MANAGEMENT LLC | 0.31M |
| RENAISSANCE TECHNOLOGIES LLC | 0.27M |
| ADAGE CAPITAL PARTNERS GP LLC | 0.25M |
| Smith, Graham & Co., Investment Advisors, LP | 0.23M |
| MORGAN STANLEY | 0.23M |
| JPMORGAN CHASE & CO | 0.23M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Tarriff Scott President and CEO | 10.17% (1425155) | EGRX / SYN / ZIOP / |
| Braunstein Douglas L | 6.81% (954210) | EGRX / |
| ProQuest Investments IV, L.P. | 1.06% (149107) | EGRX / IMDZ / URGN / |
| Moorin Jay | 0.52% (72291) | AGRX / EGRX / |
| SCHREIBER ALAIN | 0.52% (72291) | EGRX / |
| ProQuest Associates IV LLC | 0.51% (71934) | EGRX / |
| Edlin Richard A. | 0.21% (29400) | EGRX / |
| RATOFF STEVEN B | 0.11% (15664) | EGRX / |
| FLAUM SANDER A | 0.08% (11374) | EGRX / |
| Pernock David | 0.08% (10966) | EGRX / |
| ProQuest Management LLC | 0.07% (9360) | EGRX / |
| Hepner Adrian EVP and Chief Medical Officer | 0.06% (9000) | EGRX / |
| Meyers Peter A. Chief Financial Officer | 0.05% (7700) | EGRX / TLOG / |
| ProQuest Financial LLC | 0.04% (5582) | EGRX / |
| Krill Steven L. Chief Scientific Officer | 0.02% (3000) | EGRX / |
| Graves Michael | 0.01% (1000) | EGRX / |
UM